Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial (Q43244221)
Jump to navigation
Jump to search
scientific article published on 10 November 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial |
scientific article published on 10 November 2009 |
Statements
1 reference
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial (English)
1 reference
1 reference
Akseli Hemminki
1 reference
Arja Jukkola-Vuorinen
1 reference
Pirkko-Liisa Kellokumpu-Lehtinen
1 reference
Petri Bono
1 reference
Riikka Huovinen
1 reference
Minna Tanner
1 reference
Riitta Kokko
1 reference
Johan Ahlgren
1 reference
Päivi Auvinen
1 reference
Leena Helle
1 reference
Kenneth Villman
1 reference
Paul Nyandoto
1 reference
Greger Nilsson
1 reference
Raija Asola
1 reference
Outi Paija
1 reference
Marjo Pajunen
1 reference
Paula Poikonen
1 reference
Lauri Nuortio
1 reference
Sirpa-Liisa Lahtela
1 reference
Kaisa Lehtiö
1 reference
Mika Leinonen
1 reference
Henrik Lindman
1 reference
FinXX Study Investigators
1 reference
10 November 2009
1 reference
1 reference
Identifiers
1 reference